Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Donata Rimoldi
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Chemicals & Drugs
Anatomy
Physiology
Concepts & Ideas
Genes & Molecular Sequences
Procedures
Sign-in to see full Profile
Network (preview)
54
Cerottini, Jean-Charles
49
Romero, Pedro
35
Liénard, Danielle
34
Valmori, Danila
20
Speiser, Daniel
20
Guillaume, Philippe
16
Lejeune, Ferdy
16
Speiser, Daniel
15
Dutoit, Valérie
14
Pittet, Mikaël
13
Rubio-Godoy, Verena
10
Ayyoub, Maha
8
Batard, Pascal
8
Cerundolo, Vincenzo
7
Dietrich, Pierre-Yves
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Donata Rimoldi (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2008: Voelter Verena; Diserens Annie-Claire; Moulin Alexandre; Nagel Georg; Yan Pu; Migliavacca Eugenia; Rimoldi Donata; Hamou Marie-France; Kaina Bernd; Leyvraz Serge; Hegi Monika E
Infrequent promoter methylation of the MGMT gene in liver metastases from uveal melanoma.
International journal of cancer. Journal international du cancer 2008;123(5):1215-8.
-
2008: Brembilla Nicolò C; Weber Johann; Rimoldi Donata; Pradervand Sylvain; Schütz Frédéric; Pantaleo Giuseppe; Rüegg Curzio; Quadroni Manfredo; Harshman Keith; Doucey Marie-Agnès
c-Cbl expression levels regulate the functional responses of human central and effector memory CD4 T cells.
Blood 2008;112(3):652-60.
-
2008: Voelter Verena; Pica Alessia; Laurent Julien; Rimoldi Donata; Bouzourene Hanifa; Sajadi Ali; Matter Maurice; Romero Pedro; Rufer Nathalie; Speiser Daniel E
An unusual case of metastatic melanoma sensitive to chemotherapy and immunotherapy, with late immune escape in the brain.
Cancer immunity : a journal of the Academy of Cancer Immunology 2008;8():6.
-
2007: Salaun Bruno; Lebecque Serge; Matikainen Sampsa; Rimoldi Donata; Romero Pedro
Toll-like receptor 3 expressed by melanoma cells as a target for therapy?
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(15 Pt 1):4565-74.
-
2007: Elliott Bruce; Scolyer Richard A; Suciu Stefan; Lebecque Serge; Rimoldi Donata; Gugerli Oliver; Musat Elena; Sharma Raghwa N; Lienard Danielle; Keilholz Ulrich; Testori Alessandro; Eggermont Alexander; MacKie Rona; Robert Caroline; Cook Martin; Thompson John F; Angevin Eric; Spatz Alain;
Long-term protective effect of mature DC-LAMP+ dendritic cell accumulation in sentinel lymph nodes containing micrometastatic melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(13):3825-30.
-
2007: Lejeune Ferdy J; Rimoldi Donata; Speiser Daniel
New approaches in metastatic melanoma: biological and molecular targeted therapies.
Expert review of anticancer therapy 2007;7(5):701-13.
-
2006: Bioley Gilles; Jandus Camilla; Tuyaerts Sandra; Rimoldi Donata; Kwok William W; Speiser Daniel E; Tiercy Jean-Marie; Thielemans Kris; Cerottini Jean-Charles; Romero Pedro
Melan-A/MART-1-specific CD4 T cells in melanoma patients: identification of new epitopes and ex vivo visualization of specific T cells by MHC class II tetramers.
Journal of immunology (Baltimore, Md. : 1950) 2006;177(10):6769-79.
-
2006: Appay Victor; Jandus Camilla; Voelter Verena; Reynard Severine; Coupland Sarah E; Rimoldi Donata; Lienard Danielle; Guillaume Philippe; Krieg Arthur M; Cerottini Jean-Charles; Romero Pedro; Leyvraz Serge; Rufer Nathalie; Speiser Daniel E
New generation vaccine induces effective melanoma-specific CD8+ T cells in the circulation but not in the tumor site.
Journal of immunology (Baltimore, Md. : 1950) 2006;177(3):1670-8.
-
2006: Speiser Daniel E; Baumgaertner Petra; Barbey Catherine; Rubio-Godoy Verena; Moulin Alexandre; Corthesy Patricia; Devevre Estelle; Dietrich Pierre-Yves; Rimoldi Donata; Liénard Danielle; Cerottini Jean-Charles; Romero Pedro; Rufer Nathalie
A novel approach to characterize clonality and differentiation of human melanoma-specific T cell responses: spontaneous priming and efficient boosting by vaccination.
Journal of immunology (Baltimore, Md. : 1950) 2006;177(2):1338-48.
-
2006: Batard Pascal; Peterson Daniel A; Devêvre Estelle; Guillaume Philippe; Cerottini Jean-Charles; Rimoldi Donata; Speiser Daniel E; Winther Lars; Romero Pedro
Dextramers: new generation of fluorescent MHC class I/peptide multimers for visualization of antigen-specific CD8+ T cells.
Journal of immunological methods 2006;310(1-2):136-48.
-
2006: Baumgaertner Petra; Rufer Nathalie; Devevre Estelle; Derre Laurent; Rimoldi Donata; Geldhof Christine; Voelter Verena; Liénard Danielle; Romero Pedro; Speiser Daniel E
Ex vivo detectable human CD8 T-cell responses to cancer-testis antigens.
Cancer research 2006;66(4):1912-6.
-
2005: Ayyoub Maha; Merlo Andrea; Hesdorffer Charles S; Rimoldi Donata; Speiser Daniel; Cerottini Jean-Charles; Chen Yao-Tseng; Old Lloyd J; Stevanovic Stefan; Valmori Danila
CD4+ T cell responses to SSX-4 in melanoma patients.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(8):5092-9.
-
2005: Lévy Frédéric; Muehlethaler Katja; Salvi Suzanne; Peitrequin Anne-Lise; Lindholm Cecilia K; Cerottini Jean-Charles; Rimoldi Donata
Ubiquitylation of a melanosomal protein by HECT-E3 ligases serves as sorting signal for lysosomal degradation.
Molecular biology of the cell 2005;16(4):1777-87.
-
2005: Speiser Daniel E; Liénard Danielle; Rufer Nathalie; Rubio-Godoy Verena; Rimoldi Donata; Lejeune Ferdy; Krieg Arthur M; Cerottini Jean-Charles; Romero Pedro
Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909.
The Journal of clinical investigation 2005;115(3):739-46.
-
2005: Bricard Gabriel; Bouzourene Hanifa; Martinet Olivier; Rimoldi Donata; Halkic Nermin; Gillet Michel; Chaubert Pascal; Macdonald H Robson; Romero Pedro; Cerottini Jean-Charles; Speiser Daniel E
Naturally acquired MAGE-A10- and SSX-2-specific CD8+ T cell responses in patients with hepatocellular carcinoma.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(3):1709-16.
-
2005: Ayyoub Maha; Merlo Andrea; Hesdorffer Charles S; Speiser Daniel; Rimoldi Donata; Cerottini Jean-Charles; Ritter Gerd; Chen Yao-Tseng; Old Lloyd J; Stevanovic Stefan; Valmori Danila
Distinct but overlapping T helper epitopes in the 37-58 region of SSX-2.
Clinical immunology (Orlando, Fla.) 2005;114(1):70-8.
-
2004: Lahav Ronit; Suvà Mario-Luca; Rimoldi Donata; Patterson Paul H; Stamenkovic Ivan
Endothelin receptor B inhibition triggers apoptosis and enhances angiogenesis in melanomas.
Cancer research 2004;64(24):8945-53.
-
2004: Liénard Danielle; Rimoldi Donata; Marchand Marie; Dietrich Pierre-Yves; van Baren Nicolas; Geldhof Christine; Batard Pascal; Guillaume Philippe; Ayyoub Maha; Pittet Mikaël J; Zippelius Alfred; Fleischhauer Katharina; Lejeune Ferdy; Cerottini Jean-Charles; Romero Pedro; Speiser Daniel E
Ex vivo detectable activation of Melan-A-specific T cells correlating with inflammatory skin reactions in melanoma patients vaccinated with peptides in IFA.
Cancer immunity : a journal of the Academy of Cancer Immunology 2004;4():4.
-
2004: Zippelius Alfred; Batard Pascal; Rubio-Godoy Verena; Bioley Gilles; Liénard Danielle; Lejeune Ferdy; Rimoldi Donata; Guillaume Philippe; Meidenbauer Norbert; Mackensen Andreas; Rufer Nathalie; Lubenow Norbert; Speiser Daniel; Cerottini Jean-Charles; Romero Pedro; Pittet Mikaël J
Effector function of human tumor-specific CD8 T cells in melanoma lesions: a state of local functional tolerance.
Cancer research 2004;64(8):2865-73.
-
2004: Ayyoub Maha; Hesdorffer Charles S; Montes Monica; Merlo Andrea; Speiser Daniel; Rimoldi Donata; Cerottini Jean-Charles; Ritter Gerd; Scanlan Matthew; Old Lloyd J; Valmori Danila
An immunodominant SSX-2-derived epitope recognized by CD4+ T cells in association with HLA-DR.
The Journal of clinical investigation 2004;113(8):1225-33.
-
2004: Movassagh Mojgan; Spatz Alain; Davoust Jean; Lebecque Serge; Romero Pedro; Pittet Mikaël; Rimoldi Donata; Liénard Danièle; Gugerli Oliver; Ferradini Laurent; Robert Caroline; Avril Marie-Françoise; Zitvogel Laurence; Angevin Eric
Selective accumulation of mature DC-Lamp+ dendritic cells in tumor sites is associated with efficient T-cell-mediated antitumor response and control of metastatic dissemination in melanoma.
Cancer research 2004;64(6):2192-8.
-
2003: Speiser Daniel E; Pittet Mikaël J; Rimoldi Donata; Guillaume Philippe; Luescher Immanuel F; Liénard Danielle; Lejeune Ferdy; Cerottini Jean-Charles; Romero Pedro
Evaluation of melanoma vaccines with molecularly defined antigens by ex vivo monitoring of tumor-specific T cells.
Seminars in cancer biology 2003;13(6):461-72.
-
2003: Valmori Danila; Dutoit Valérie; Ayyoub Maha; Rimoldi Donata; Guillaume Philippe; Liénard Danielle; Lejeune Ferdy; Cerottini Jean-Charles; Romero Pedro; Speiser Daniel E
Simultaneous CD8+ T cell responses to multiple tumor antigen epitopes in a multipeptide melanoma vaccine.
Cancer immunity : a journal of the Academy of Cancer Immunology 2003;3():15.
-
2003: Rimoldi Donata; Lemoine Robert; Kurt Anne-Marie; Salvi Suzanne; Berset Magali; Matter Maurice; Roche Bruno; Cerottini Jean-Philippe; Guggisberg David; Krischer Joachim; Braun Ralph; Willi Jean-Pierre; Antonescu Christian; Slosman Daniel; Lejeune Ferdy J; Liénard Danielle;
Detection of micrometastases in sentinel lymph nodes from melanoma patients: direct comparison of multimarker molecular and immunopathological methods.
Melanoma research 2003;13(5):511-20.
-
2003: Rimoldi Donata; Salvi Suzanne; Liénard Danielle; Lejeune Ferdy J; Speiser Daniel; Zografos Leonidas; Cerottini Jean-Charles
Lack of BRAF mutations in uveal melanoma.
Cancer research 2003;63(18):5712-5.
-
2003: Ayyoub Maha; Rimoldi Donata; Guillaume Philippe; Romero Pedro; Cerottini Jean-Charles; Valmori Danila; Speiser Daniel
Tumor-reactive, SSX-2-specific CD8+ T cells are selectively expanded during immune responses to antigen-expressing tumors in melanoma patients.
Cancer research 2003;63(17):5601-6.
-
2003: Speiser Daniel E; Rimoldi Donata; Batard Pascal; Liénard Danielle; Lejeune Ferdy; Cerottini Jean-Charles; Romero Pedro
Disease-driven T cell activation predicts immune responses to vaccination against melanoma.
Cancer immunity : a journal of the Academy of Cancer Immunology 2003;3():12.
-
2003: Ayyoub Maha; Zippelius Alfred; Pittet Mikaël J; Rimoldi Donata; Valmori Danila; Cerottini Jean-Charles; Romero Pedro; Lejeune Ferdy; Liénard Danielle; Speiser Daniel E
Activation of human melanoma reactive CD8+ T cells by vaccination with an immunogenic peptide analog derived from Melan-A/melanoma antigen recognized by T cells-1.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(2):669-77.
-
2002: Romero Pedro; Pittet Mikael; Dutoit Valerie; Zippelius Alfred; Liénard Danielle; Lejeune Ferdy; Guillaume Philippe; Rimoldi Donata; Valmori Danila; Speiser Daniel E; Cerottini Jean-Charles
Therapeutic cancer vaccines based on molecularly defined human tumor antigens.
Vaccine 2002;20 Suppl 4():A2-7.
-
2002: Romero Pedro; Valmori Danila; Pittet Mikael J; Zippelius Alfred; Rimoldi Donata; Lévy Frederic; Dutoit Valérie; Ayyoub Maha; Rubio-Godoy Verena; Michielin Olivier; Guillaume Philippe; Batard Pascal; Luescher Immanuel F; Lejeune Ferdy; Liénard Danielle; Rufer Nathalie; Dietrich Pierre-Yves; Speiser Daniel E; Cerottini Jean-Charles
Antigenicity and immunogenicity of Melan-A/MART-1 derived peptides as targets for tumor reactive CTL in human melanoma.
Immunological reviews 2002;188():81-96.
-
2002: De Mazière Ann M; Muehlethaler Katja; van Donselaar Elly; Salvi Suzanne; Davoust Jean; Cerottini Jean-Charles; Lévy Frédéric; Slot Jan W; Rimoldi Donata
The melanocytic protein Melan-A/MART-1 has a subcellular localization distinct from typical melanosomal proteins.
Traffic (Copenhagen, Denmark) 2002;3(9):678-93.
-
2002: Rubio-Godoy Verena; Ayyoub Maha; Dutoit Valerie; Servis Catherine; Schink Amy; Rimoldi Donata; Romero Pedro; Cerottini Jean-Charles; Simon Richard; Zhao Yindong; Houghten Richard A; Pinilla Clemencia; Valmori Danila
Combinatorial peptide library-based identification of peptide ligands for tumor-reactive cytolytic T lymphocytes of unknown specificity.
European journal of immunology 2002;32(8):2292-9.
-
2002: Valmori Danila; Dutoit Valerie; Schnuriger Valerie; Quiquerez Anne-Lise; Pittet Mikaël J; Guillaume Philippe; Rubio-Godoy Verena; Walker Paul R; Rimoldi Donata; Liénard Danielle; Cerottini Jean-Charles; Romero Pedro; Dietrich Pierre-Yves
Vaccination with a Melan-A peptide selects an oligoclonal T cell population with increased functional avidity and tumor reactivity.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(8):4231-40.
-
2002: Valmori Danila; Scheibenbogen Carmen; Dutoit Valerie; Nagorsen Dirk; Asemissen Anne Marie; Rubio-Godoy Verena; Rimoldi Donata; Guillaume Philippe; Romero Pedro; Schadendorf Dirk; Lipp Martin; Dietrich Pierre-Yves; Thiel Eckhard; Cerottini Jean-Charles; Liénard Danielle; Keilholz Ulrich
Circulating Tumor-reactive CD8(+) T cells in melanoma patients contain a CD45RA(+)CCR7(-) effector subset exerting ex vivo tumor-specific cytolytic activity.
Cancer research 2002;62(6):1743-50.
-
2002: Speiser Daniel E; Liénard Danielle; Pittet Mikaël J; Batard Pascal; Rimoldi Donata; Guillaume Philippe; Cerottini Jean-Charles; Romero Pedro
In vivo activation of melanoma-specific CD8(+) T cells by endogenous tumor antigen and peptide vaccines. A comparison to virus-specific T cells.
European journal of immunology 2002;32(3):731-41.
-
2002: Ayyoub Maha; Stevanovic Stefan; Sahin Ugur; Guillaume Philippe; Servis Catherine; Rimoldi Donata; Valmori Danila; Romero Pedro; Cerottini Jean-Charles; Rammensee Hans-Georg; Pfreundschuh Michael; Speiser Daniel; Lévy Frédéric
Proteasome-assisted identification of a SSX-2-derived epitope recognized by tumor-reactive CTL infiltrating metastatic melanoma.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(4):1717-22.
-
2002: Dutoit Valérie; Rubio-Godoy Verena; Doucey Marie-Agnès; Batard Pascal; Liénard Danielle; Rimoldi Donata; Speiser Daniel; Guillaume Philippe; Cerottini Jean-Charles; Romero Pedro; Valmori Danila
Functional avidity of tumor antigen-specific CTL recognition directly correlates with the stability of MHC/peptide multimer binding to TCR.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(3):1167-71.
-
2001: Rimoldi D; Muehlethaler K; Salvi S; Valmori D; Romero P; Cerottini J C; Levy F
Subcellular localization of the melanoma-associated protein Melan-AMART-1 influences the processing of its HLA-A2-restricted epitope.
The Journal of biological chemistry 2001;276(46):43189-96.
-
2001: Rubio-Godoy V; Dutoit V; Rimoldi D; Lienard D; Lejeune F; Speiser D; Guillaume P; Cerottini J C; Romero P; Valmori D
Discrepancy between ELISPOT IFN-gamma secretion and binding of A2/peptide multimers to TCR reveals interclonal dissociation of CTL effector function from TCR-peptide/MHC complexes half-life.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(18):10302-7.
-
2001: Dutoit V; Rubio-Godoy V; Dietrich P Y; Quiqueres A L; Schnuriger V; Rimoldi D; Liénard D; Speiser D; Guillaume P; Batard P; Cerottini J C; Romero P; Valmori D
Heterogeneous T-cell response to MAGE-A10(254-262): high avidity-specific cytolytic T lymphocytes show superior antitumor activity.
Cancer research 2001;61(15):5850-6.
-
2001: Pittet M J; Speiser D E; Liénard D; Valmori D; Guillaume P; Dutoit V; Rimoldi D; Lejeune F; Cerottini J C; Romero P
Expansion and functional maturation of human tumor antigen-specific CD8+ T cells after vaccination with antigenic peptide.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(3 Suppl):796s-803s.
-
2001: Romero P; Dutoit V; Rubio-Godoy V; Liénard D; Speiser D; Guillaume P; Servis K; Rimoldi D; Cerottini J C; Valmori D
CD8+ T-cell response to NY-ESO-1: relative antigenicity and in vitro immunogenicity of natural and analogue sequences.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(3 Suppl):766s-772s.
-
2001: Berset M; Cerottini J P; Guggisberg D; Romero P; Burri F; Rimoldi D; Panizzon R G
Expression of Melan-A/MART-1 antigen as a prognostic factor in primary cutaneous melanoma.
International journal of cancer. Journal international du cancer 2001;95(1):73-7.
-
2001: Valmori D; Dutoit V; Rubio-Godoy V; Chambaz C; Liénard D; Guillaume P; Romero P; Cerottini J C; Rimoldi D
Frequent cytolytic T-cell responses to peptide MAGE-A10(254-262) in melanoma.
Cancer research 2001;61(2):509-12.
-
2000: Rimoldi D; Rubio-Godoy V; Dutoit V; Lienard D; Salvi S; Guillaume P; Speiser D; Stockert E; Spagnoli G; Servis C; Cerottini J C; Lejeune F; Romero P; Valmori D
Efficient simultaneous presentation of NY-ESO-1/LAGE-1 primary and nonprimary open reading frame-derived CTL epitopes in melanoma.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(12):7253-61.
-
2000: Valmori D; Dutoit V; Liénard D; Rimoldi D; Pittet M J; Champagne P; Ellefsen K; Sahin U; Speiser D; Lejeune F; Cerottini J C; Romero P
Naturally occurring human lymphocyte antigen-A2 restricted CD8+ T-cell response to the cancer testis antigen NY-ESO-1 in melanoma patients.
Cancer research 2000;60(16):4499-506.
-
2000: Valmori D; Dutoit V; Liénard D; Lejeune F; Speiser D; Rimoldi D; Cerundolo V; Dietrich P Y; Cerottini J C; Romero P
Tetramer-guided analysis of TCR beta-chain usage reveals a large repertoire of melan-A-specific CD8+ T cells in melanoma patients.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(1):533-8.
-
2000: Valmori D; Lévy F; Miconnet I; Zajac P; Spagnoli G C; Rimoldi D; Liénard D; Cerundolo V; Cerottini J C; Romero P
Induction of potent antitumor CTL responses by recombinant vaccinia encoding a melan-A peptide analogue.
Journal of immunology (Baltimore, Md. : 1950) 2000;164(2):1125-31.
-
1999: Valmori D; Fonteneau J F; Valitutti S; Gervois N; Dunbar R; Liénard D; Rimoldi D; Cerundolo V; Jotereau F; Cerottini J C; Speiser D E; Romero P
Optimal activation of tumor-reactive T cells by selected antigenic peptide analogues.
International immunology 1999;11(12):1971-80.
-
1999: Serrano A; Lethé B; Delroisse J M; Lurquin C; De Plaen E; Brasseur F; Rimoldi D; Boon T
Quantitative evaluation of the expression of MAGE genes in tumors by limiting dilution of cDNA libraries.
International journal of cancer. Journal international du cancer 1999;83(5):664-9.
-
1999: Speiser D E; Pittet M J; Valmori D; Dunbar R; Rimoldi D; Liénard D; MacDonald H R; Cerottini J C; Cerundolo V; Romero P
In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes.
The Journal of experimental medicine 1999;190(6):775-82.
-
1999: Rimoldi D; Salvi S; Reed D; Coulie P; Jongeneel V C; De Plaen E; Brasseur F; Rodriguez A M; Boon T; Cerottini J C
cDNA and protein characterization of human MAGE-10.
International journal of cancer. Journal international du cancer 1999;82(6):901-7.
-
1999: Valmori D; Pittet M J; Vonarbourg C; Rimoldi D; Liénard D; Speiser D; Dunbar R; Cerundolo V; Cerottini J C; Romero P
Analysis of the cytolytic T lymphocyte response of melanoma patients to the naturally HLA-A*0201-associated tyrosinase peptide 368-376.
Cancer research 1999;59(16):4050-5.
-
1999: Speiser D E; Valmori D; Rimoldi D; Pittet M J; Liénard D; Cerundolo V; MacDonald H R; Cerottini J C; Romero P
CD28-negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patients.
European journal of immunology 1999;29(6):1990-9.
-
1999: Valmori D; Pittet M J; Rimoldi D; Liénard D; Dunbar R; Cerundolo V; Lejeune F; Cerottini J C; Romero P
An antigen-targeted approach to adoptive transfer therapy of cancer.
Cancer research 1999;59(9):2167-73.
-
1999: Men Y; Miconnet I; Valmori D; Rimoldi D; Cerottini J C; Romero P
Assessment of immunogenicity of human Melan-A peptide analogues in HLA-A*0201/Kb transgenic mice.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(6):3566-73.
-
1998: Valmori D; Gervois N; Rimoldi D; Fonteneau J F; Bonelo A; Liénard D; Rivoltini L; Jotereau F; Cerottini J C; Romero P
Diversity of the fine specificity displayed by HLA-A*0201-restricted CTL specific for the immunodominant Melan-A/MART-1 antigenic peptide.
Journal of immunology (Baltimore, Md. : 1950) 1998;161(12):6956-62.
-
1998: Romero P; Dunbar P R; Valmori D; Pittet M; Ogg G S; Rimoldi D; Chen J L; Liénard D; Cerottini J C; Cerundolo V
Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes.
The Journal of experimental medicine 1998;188(9):1641-50.
-
1998: Hahne M; Kataoka T; Schröter M; Hofmann K; Irmler M; Bodmer J L; Schneider P; Bornand T; Holler N; French L E; Sordat B; Rimoldi D; Tschopp J
APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth.
The Journal of experimental medicine 1998;188(6):1185-90.
-
1998: Renno T; Attinger A; Rimoldi D; Hahne M; Tschopp J; MacDonald H R
Expression of B220 on activated T cell blasts precedes apoptosis.
European journal of immunology 1998;28(2):540-7.
-
1998: Valmori D; Fonteneau J F; Lizana C M; Gervois N; Liénard D; Rimoldi D; Jongeneel V; Jotereau F; Cerottini J C; Romero P
Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues.
Journal of immunology (Baltimore, Md. : 1950) 1998;160(4):1750-8.
-
1998: Cerottini J C; Valmori D; Rimoldi D; Romero P
Human tumor immunotherapy. New opportunities as well as new challenges.
Advances in experimental medicine and biology 1998;451():247-50.
-
1997: Reed D S; Romero P; Rimoldi D; Cerottini J C; Schaack J; Jongeneel C V
Construction and characterization of a recombinant adenovirus directing expression of the MAGE-1 tumor-specific antigen.
International journal of cancer. Journal international du cancer 1997;72(6):1045-55.
-
1997: Hartmann R R; Rimoldi D; Lejeune F J; Carrel S
Cell differentiation and cell-cycle alterations by tyrosine kinase inhibitors in human melanoma cells.
Melanoma research 1997;7 Suppl 2():S27-33.
-
1997: Irmler M; Thome M; Hahne M; Schneider P; Hofmann K; Steiner V; Bodmer J L; Schröter M; Burns K; Mattmann C; Rimoldi D; French L E; Tschopp J
Inhibition of death receptor signals by cellular FLIP.
Nature 1997;388(6638):190-5.
-
1997: Waanders G A; Rimoldi D; Liénard D; Carrel S; Lejeune F; Dietrich P Y; Cerottini J C; Romero P
Melanoma-reactive human cytotoxic T lymphocytes derived from skin biopsies of delayed-type hypersensitivity reactions induced by injection of an autologous melanoma cell line.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(5):685-96.
-
1997: Valmori D; Liénard D; Waanders G; Rimoldi D; Cerottini J C; Romero P
Analysis of MAGE-3-specific cytolytic T lymphocytes in human leukocyte antigen-A2 melanoma patients.
Cancer research 1997;57(4):735-41.
-
1996: Hahne M; Rimoldi D; Schröter M; Romero P; Schreier M; French L E; Schneider P; Bornand T; Fontana A; Lienard D; Cerottini J; Tschopp J
Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape.
Science (New York, N.Y.) 1996;274(5291):1363-6.
-
1996: Carrel S; Schreyer M; Spagnoli G; Cerottini J C; Rimoldi D
Monoclonal antibodies against recombinant-MAGE-1 protein identify a cross-reacting 72-kDa antigen which is co-expressed with MAGE-1 protein in melanoma cells.
International journal of cancer. Journal international du cancer 1996;67(3):417-22.
-
1996: Mulcahy K A; Rimoldi D; Brasseur F; Rodgers S; Liénard D; Marchand M; Rennie I G; Murray A K; McIntyre C A; Platts K E; Leyvraz S; Boon T; Rees R C
Infrequent expression of the MAGE gene family in uveal melanomas.
International journal of cancer. Journal international du cancer 1996;66(6):738-42.
-
1996: Luescher I F; Romero P; Kuznetsov D; Rimoldi D; Coulie P; Cerottini J C; Jongeneel C V
HLA photoaffinity labeling reveals overlapping binding of homologous melanoma-associated gene peptides by HLA-A1, HLA-A29, and HLA-B44.
The Journal of biological chemistry 1996;271(21):12463-71.
-
1995: Brasseur F; Rimoldi D; Liénard D; Lethé B; Carrel S; Arienti F; Suter L; Vanwijck R; Bourlond A; Humblet Y
Expression of MAGE genes in primary and metastatic cutaneous melanoma.
International journal of cancer. Journal international du cancer 1995;63(3):375-80.
-
1995: Carrel S; Hartmann F; Salvi S; Albrecht H; Schreyer M; Rimoldi D
Expression of type A and B tumor necrosis factor (TNF) receptors on melanoma cells can be regulated by dbc-AMP and IFN gamma.
International journal of cancer. Journal international du cancer 1995;62(1):76-83.
-
1994: Carrel S; Salvi S; Hartmann F; Rimoldi D
Recognition of HLA-A1 by murine monoclonal antibodies.
Tissue antigens 1994;43(2):110-5.
-
1993: Carrel S; Zografos L; Schreyer M; Rimoldi D
Expression of CALLA/CD10 on human melanoma cells.
Melanoma research 1993;3(5):319-23.
-
1993: Plaisance S; Rubinstein E; Alileche A; Han D S; Sahraoui Y; Mingari M C; Bellomo R; Rimoldi D; Colombo M P; Jasmin C
Human melanoma cells express a functional interleukin-2 receptor.
International journal of cancer. Journal international du cancer 1993;55(1):164-70.
-
1993: Rimoldi D; Salvi S; Hartmann F; Schreyer M; Blum S; Zografos L; Plaisance S; Azzarone B; Carrel S
Expression of IL-2 receptors in human melanoma cells.
Anticancer research 1993;13(3):555-64.
-
1993: Carrel S; Rimoldi D
Melanoma-associated antigens.
European journal of cancer (Oxford, England : 1990) 1993;29A(13):1903-7.
-
1991: Hayoz D; Rimoldi D; Kühn L; Mach J P; Carrel S
Cloning of an interferon-gamma regulated human melanoma-associated antigen: identity to the intercellular adhesion molecule ICAM-1.
Melanoma research 1991;1(4):251-9.
Sign-in to see more
